Advances in Oncology, 2024

Contemporary Management of Dermatofibrosarcoma Protuberans
Management of Locoregional Melanoma
Current Management of Intraductal Papillary Mucinous Neoplasms
Perioperative Strategies in Non-Small Cell Lung Cancer: Immunotherapy and Targeted Therapy
Optimal Front-Line Therapy for Non[1]Oncogene-Driven Non-Small Cell Lung Cancer
Beyond First-Line Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitors (TKI): Approach to Resistance
Antibody-Drug Conjugates for the Treatment of Gynecologic Cancer: A Review of the Current Evidence and Clinical Application
Surgery for Recurrent Ovarian Cancer
Big Data in Pediatric Oncology: Hope, Hype, Reality
Imipridones and Dopamine Receptor Antagonism in the Therapeutic Management of Gliomas
Diagnostic and Theranostic Opportunities in Neuro-Oncology
Updates on Revised Diagnostic Criteria and Targeted Therapies for Neurofibromatosis
Management of Relapsed Refractory Large B[1]Cell Non-Hodgkin Lymphoma: Chimeric Antigen Receptor T-Cell Therapy versus Autologous Stem Cell Transplantation
T-cell Acute Lymphoblastic Leukemia: Novel Therapies Worth Watching
Prognostic Role and Clinical Utility of Measurable Residual Disease in Acute Myeloid Leukemia
Role of Circulating Tumor DNA for Monitoring of Recurrence and Treatment Response in Urothelial Cancer
Intensification of Androgen Deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer: Patient Selection and Overview of Doublet and Triplet Therapy Data
Adjuvant Therapy for Muscle-Invasive Urothelial Cancer: Current Evidence and Future Directions
Defining the Role of Neoadjuvant Therapy for Gastroesophageal Cancers
Current and Emerging Therapeutic Options for Human Epidermal Growth Factor Receptor 2-Expressing Gastroesophageal Cancers
Contemporary Systemic Therapy Approaches for Unresectable Hepatocellular Carcinoma
Multidisciplinary Care and Multimodal Treatment Approaches for Unresectable Hepatocellular Carcinoma